{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:18:47Z","timestamp":1764688727112},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T00:00:00Z","timestamp":1241481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10072-009-0087-x","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T18:04:19Z","timestamp":1241460259000},"page":"353-359","source":"Crossref","is-referenced-by-count":36,"title":["Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study"],"prefix":"10.1007","volume":"30","author":[{"given":"Loredana","family":"Dinapoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Maschio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Jandolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Fabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sperati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Muti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,5]]},"reference":[{"key":"87_CR1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/pon.898","volume":"14","author":"T Edvardsson","year":"2005","unstructured":"Edvardsson T, Ahlstr\u00f6m G (2005) Illness-related problems and coping among persons with low-grade glioma. Psychooncology 14:728\u2013737","journal-title":"Psychooncology"},{"key":"87_CR2","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(02)11398-5","volume":"360","author":"M Klein","year":"2002","unstructured":"Klein M, Heimans JJ, Aaronson NK et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low grade gliomas: a comparative study. Lancet 360:1361\u20131368","journal-title":"Lancet"},{"key":"87_CR3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1227\/01.NEU.0000159648.44507.7F","volume":"56","author":"A Mainio","year":"2005","unstructured":"Mainio A, Hakko H, Timonen M, Niemel\u00e4 A, Koivukangas J, R\u00e4s\u00e4nen P (2005) Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56:1234\u20131241","journal-title":"Neurosurgery"},{"key":"87_CR4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.clineuro.2007.05.017","volume":"109","author":"LM Lynam","year":"2007","unstructured":"Lynam LM, Lyons MK, Drazkowski JF, Sirven JI, Noe KH, Zimmerman RS, Wilkens JA (2007) Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109:634\u2013638","journal-title":"Clin Neurol Neurosurg"},{"key":"87_CR5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MS Breemen van","year":"2007","unstructured":"van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumors: epidemiology, mechanisms, and management. Lancet Neurol 6:421\u2013430","journal-title":"Lancet Neurol"},{"key":"87_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","volume":"80","author":"M Maschio","year":"2006","unstructured":"Maschio M, Albani F, Baruzzi A et al (2006) Levetiracetam therapy in patients with brain tumor and epilepsy. J Neurooncol 80:97\u2013100","journal-title":"J Neurooncol"},{"key":"87_CR7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","volume":"54","author":"M Klein","year":"2003","unstructured":"Klein M, Engelberts NH, van der Ploeg HM et al (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514\u2013520","journal-title":"Ann Neurol"},{"key":"87_CR8","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"MJ Glantz","year":"2000","unstructured":"Glantz MJ, Cole BF, Forsyth PA et al (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886\u20131893","journal-title":"Neurology"},{"key":"87_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255\u2013260","journal-title":"J Neurooncol"},{"key":"87_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00007691-200408000-00006","volume":"26","author":"M Contin","year":"2004","unstructured":"Contin M, Albani F, Riva R, Baruzzi A (2004) Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit 26:375\u2013379","journal-title":"Ther Drug Monit"},{"key":"87_CR11","first-page":"15","volume":"21","author":"M Maschio","year":"2006","unstructured":"Maschio M, Dinapoli L, Zarabla A, Jandolo B (2006) Issues related to the pharmacological management of patients with brain tumors and epilepsy. Funct Neurol 21:15\u201319","journal-title":"Funct Neurol"},{"key":"87_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11060-005-9070-4","volume":"78","author":"HB Newton","year":"2006","unstructured":"Newton HB, Goldlust SA, Pearl D (2006) Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78:99\u2013102","journal-title":"J Neurooncol"},{"key":"87_CR13","unstructured":"Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events v3.0, DCTD, NCI, NIH, DHHS. http:\/\/ctep.cancer.gov . Accessed 12 December 2003"},{"key":"87_CR14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/A:1008264412398","volume":"9","author":"G Apolone","year":"1998","unstructured":"Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P (1998) Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 9:549\u2013557","journal-title":"Ann Oncol"},{"key":"87_CR15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1525-5050(03)00004-0","volume":"4","author":"JA Cramer","year":"2003","unstructured":"Cramer JA, Van Hamm\u00e9e G, N132 Study Group (2003) Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy Behav 4:118\u2013123","journal-title":"Epilepsy Behav"},{"key":"87_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","volume":"62","author":"FG Gilliam","year":"2004","unstructured":"Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H (2004) Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62:23\u201327","journal-title":"Neurology"},{"key":"87_CR17","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1200\/JCO.2003.04.172","volume":"21","author":"PD Brown","year":"2003","unstructured":"Brown PD, Buckner JC, O\u2019Fallon JR et al (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol 21:2519\u20132524","journal-title":"J Clin Oncol"},{"key":"87_CR18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.1951.03810040002001","volume":"87","author":"DA Karnofsky","year":"1951","unstructured":"Karnofsky DA, Burchenal JH, Armistead GC, Southam CM, Bernstein JL, Craver LF, Rhoads CP (1951) Triethylene melamine in the treatment of neoplastic disease. Arch Int Med 87:477\u2013516","journal-title":"Arch Int Med"},{"key":"87_CR19","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61\u201365","journal-title":"Md State Med J"},{"key":"87_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007010050001","volume":"142","author":"A Beaumont","year":"2000","unstructured":"Beaumont A, Whittle IR (2000) The pathogenesis of tumor associated epilepsy. Acta Neurochir 142:1\u201315","journal-title":"Acta Neurochir"},{"key":"87_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","volume":"52","author":"S Baltes","year":"2007","unstructured":"Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, L\u00f6scher W (2007) Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52:333\u2013346","journal-title":"Neuropharmacology"},{"key":"87_CR22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/annonc\/mdg371","volume":"14","author":"M Brada","year":"2003","unstructured":"Brada M, Viviers L, Abson C et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715\u20131721","journal-title":"Ann Oncol"},{"key":"87_CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2005.00506.x","volume":"181","author":"E Perucca","year":"2005","unstructured":"Perucca E, Meador KJ (2005) Adverse effects of antiepileptic drugs. Acta Neurol Scand Suppl 181:30\u201335","journal-title":"Acta Neurol Scand Suppl"},{"key":"87_CR24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/neuonc\/5.2.89","volume":"5","author":"CA Meyers","year":"2003","unstructured":"Meyers CA, Hess KR (2003) Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro Oncol 5:89\u201395","journal-title":"Neuro Oncol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0087-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-009-0087-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-009-0087-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:11:40Z","timestamp":1559106700000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-009-0087-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,5]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s10072-009-0087-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,5]]}}}